Lily's cheap weight loss drugs hurt him stock Lily has announced price reductions for the two lowest doses of its obesity drug Zep bound tzip atide when purchased through its direct to Consumer Channel Lily direct the new prices for 2.5 MGR and 5 MGR doses will be at least 50% lower than the list prices of other glp1 obesity medications but only for self-pay customers and not for insurance covered doses this move follows a similar strategy by hims and hers who in May announced plans to offer discounted compounded versions of sem glutide which is also sold as the type 2 diabetes Med OIC starting at $199 a month HS is also offering a $79 a month plan for an oral version of semaglutide that is also known as novo's diabetes pill rib elsis